Evommune Inc.

EVMN | NYSE

Price Alert Chart Builder DCF Calculator

$6.73

-$0.08 (-1.25%)

At close: Oct 30, 2026, 4:00 PM ET

$6.73

$0.00 (0.00%)

Pre-market: Nov 2, 2026, 4:17 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-1.25%

(1D)

No price chart data available for 1D timeframe.

Rating

Updated: Nov 2, 2026

+15.5 pts

Fundamentals Average

Market Sentiment Neutral

Moat None

Sector Rank #395/1028 (Top 38%)

Full Analysis

Key Statistics

Market Data

Market Cap $244.25M

1D Range

6.29 6.84

52W Range

5.10 31.57

Valuation (TTM)

PE -2.38

PB 0.88

EV/EBITDA -0.54

Valuation (NTM)

Forward PE N/A

Forward PEG 0.07

Price Target $25.00

Cash Flow

FCF Yield -30.6%

SBC Adj. FCF Yield -32.5%

SBC Impact -6.2%

Margins

Gross Margin 100.0%

Operating Margin -1018.9%

FCF Margin -746.5%

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y N/A | N/A

FCF 3Y | 5Y N/A | N/A

Returns

ROA -31.4%

ROE -62.6%

ROIC -35.7%

Financial Health

Net Cash

$200.79M

Current Ratio 11.68

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Evommune, Inc. is a United States-based clinical-stage biotechnology company dedicated to advancing novel therapeutic solutions. Their primary focus lies in addressing the underlying mechanisms of chr...

Sector Healthcare

Industry Biotechnology

Employees 48

IPO Date Nov 6, 2025

Website www.evommune.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$22.00

Upside

+226.89%

Buy (3)

Hold (2)

Sell (0)

Analyst Details ➞